The US Food and Drug Administration (FDA) yesterday removed a key limitation on the use of real-world evidence (RWE) used in ...
UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved pharma major GSK’s Exdensur (depemokimab), the first twice-yearly biological medicine for use as an add-on treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback